Hip osteoarthritis and the risk of all-cause and disease-specific mortality in older women: A population-based cohort study

Arthritis and Rheumatology

Volumn 67, Issue 7, 2015, Pages 1798-1805

  Barbour, Kamil E ^a   Lui, Li Yung ^b   Nevitt, Michael C ^c   Murphy, Louise B ^a   Helmick, Charles G ^a   Theis, Kristina A ^a   Hochberg, Marc C ^d   Lane, Nancy E ^e   Hootman, Jennifer M ^a   Cauley, Jane A ^f  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; DEATH CERTIFICATE; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; GASTROINTESTINAL DISEASE; HIP OSTEOARTHRITIS; HIP RADIOGRAPHY; HOSPITAL DISCHARGE; HUMAN; JOINT CAVITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OSTEOPHYTE; PRIORITY JOURNAL; UNITED STATES; ARTHRALGIA; CLINICAL TRIAL; DISABILITY; HIP; INCIDENCE; MULTICENTER STUDY; NEOPLASM; OSTEOARTHRITIS, HIP; PROSPECTIVE STUDY; RADIOGRAPHY; RISK FACTOR; VERY ELDERLY;

NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRALGIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; GASTROINTESTINAL DISEASES; HIP JOINT; HUMANS; INCIDENCE; MORTALITY; NEOPLASMS; OSTEOARTHRITIS, HIP; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84933055937     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39113     Document Type: Article

References (40)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum 2008; 58: 26-35.
2. Kadam U, Jordan K, Croft P., Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis 2004; 63: 408-14.
3. Haugen IK, Ramachandran VS, Misra D, Neogi T, Niu J, Yang T, et al., Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: data from the Framingham Heart Study. Ann Rheum Dis 2015; 74: 74-81.
4. Nuesch E, Dieppe P, Reichenbach S, Williams S, Iff S, Juni P. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 2011; 342: d1165.
5. Hochberg M., Mortality in osteoarthritis. Clin Exp Rheumatol 2008; 26 Suppl 51: S120-4.
6. Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J, et al., Prevalence of hip symptoms and radiographic and symptomatic hip osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol 2009; 36: 809-15.
7. Chaganti RK, Parimi N, Cawthon P, Dam TL, Nevitt MC, Lane NE., Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the Osteoporotic Fractures in Men Study. Arthritis Rheum 2010; 62: 511-4.
8. Nevitt MC, Lane NE, Scott JC, Hochberg MC, Pressman AR, Genant HK, et al, and the Study of Osteoporotic Fractures Research Group. Radiographic osteoarthritis of the hip and bone mineral density. Arthritis Rheum 1995; 38: 907-16.
9. Kim S., Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997-2004. Arthritis Rheum 2008; 59: 481-8.
10. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al, for the Study of Osteoporotic Fractures Research Group. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767-73.
11. LaCroix AZ, Lee JS, Wu L, Cauley JA, Shlipak MG, Ott SM, et al., Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc 2008; 56: 1434-41.
12. Croft P, Cooper C, Wickham C, Coggon D., Defining osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol 1990; 132: 514-22.
13. Kellgren J, Lawrence J., Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494-502.
14. Lane NE, Gore LR, Cummings SR, Hochberg MC, Scott JC, Williams EN, et al, for the Study of Osteoporotic Fractures Research Group. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Arthritis Rheum 1999; 42: 854-60.
15. Lane NE, Nevitt MC, Hochberg MC, Hung YY, Palermo L., Progression of radiographic hip osteoarthritis over eight years in a community sample of elderly white women. Arthritis Rheum 2004; 50: 1477-86.
16. Arden NK, Lane NE, Parimi N, Javaid KM, Lui LY, Hochberg MC, et al., Defining incident radiographic hip osteoarthritis for epidemiologic studies in women. Arthritis Rheum 2009; 60: 1052-9.
17. Vogt MT, Cauley JA, Kuller LH, Nevitt MC., Functional status and mobility among elderly women with lower extremity arterial disease: the Study of Osteoporotic Fractures. J Am Geriatr Soc 1994; 42: 923-9.
18. Lunn M, McNeil D., Applying Cox regression to competing risks. Biometrics 1995; 51: 524-32.
19. Satagopan J, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach A., A note on competing risks in survival data analysis. Br J Cancer 2004; 91: 1229-35.
20. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-38.
21. Murphy SL, Xu J, Kochanek KD., Deaths: final data for 2010. Natl Vital Stat Rep 2013; 61: 1-117.
22. Lange T, Vansteelandt S, Bekaert M., A simple unified approach for estimating natural direct and indirect effects. Am J Epidemiol 2012; 176: 190-5.
23. Pedersen AB, Baron JA, Overgaard S, Johnsen SP., Short-, and, long-, term mortality following primary total hip replacement for osteoarthritis: a Danish nationwide epidemiological study. J Bone Joint Surg Br 2011; 93: 172-7.
24. Barrett J, Losina E, Baron JA, Mahomed NN, Wright J, Katz JN., Survival following total hip replacement. J Bone Joint Surg Am 2005; 87: 1965-71.
25. Dunlop DD, Song J, Semanik PA, Chang RW, Sharma L, Bathon JM, et al., Objective physical activity measurement in the Osteoarthritis Initiative: are guidelines being met? Arthritis Rheum 2011; 63: 3372-82.
26. Leitzmann MF, Park Y, Blair A, Ballard-Barbash R, Mouw T, Hollenbeck AR, et al., Physical activity recommendations and decreased risk of mortality. Arch Intern Med 2007; 167: 2453-60.
27. Kelley GA, Kelley KS, Hootman JM, Jones DL., Effects of community-deliverable exercise on pain and physical function in adults with arthritis and other rheumatic diseases: a meta-analysis. Arthritis Care Res (Hoboken) 2011; 63: 79-93.
28. Idler EL, Benyamini Y., Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 1997; 38: 21-37.
29. Brady TJ, Murphy L, O'Colmain BJ, Beauchesne D, Daniels B, Greenberg M, et al., A meta-analysis of health status, health behaviors, and health care utilization outcomes of the Chronic Disease Self-Management Program. Prev Chronic Dis 2013; 10: 120112.
30. Jones ME, Swerdlow AJ., Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths. Am J Epidemiol 1998; 148: 1012-7.
31. Rahman MM, Kopec JA, Anis AH, Cibere J, Goldsmith CH., Risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study. Arthritis Care Res (Hoboken) 2013; 65: 1951-8.
32. Hoeven TA, Leening MJ, Bindels PJ, Castano-Betancourt M, van Meurs JB, Franco OH, et al., Disability and not osteoarthritis predicts cardiovascular disease: a prospective population-based cohort study. Ann Rheum Dis 2015; 74: 752-6.
33. Newman AB, Simonsick EM, Naydeck BL, Boudreau RM, Kritchevsky SB, Nevitt MC, et al., Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA 2006; 295: 2018-26.
34. Sokolove J, Lepus CM., Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis 2013; 5: 77-94.
35. Il'yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S, et al., Circulating levels of inflammatory markers and cancer risk in the Health Aging and Body Composition cohort. Cancer Epidemiol Biomarkers Prev 2005; 14: 2413-8.
36. Sacks JJ, Helmick CG, Langmaid G., Deaths from arthritis and other rheumatic conditions, United States, 1979-1998. J Rheumatol 2004; 31: 1823-8.
37. Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron J, et al., Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013; 382: 769-79.
38. Macfarlane GJ, McBeth J, Silman AJ., Widespread body pain and mortality: prospective population based study. BMJ 2001; 323: 662.
39. Crombie IK., Commentary: an interesting finding, but what does it mean? BMJ 2001; 323: 662.
40. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al., Gait speed and survival in older adults. JAMA 2011; 305: 50-8.